This website was commissioned and funded by Santen.
The Future of Glaucoma
A clear vision for a better tomorrow: The Future of Glaucoma can be brighter
The Future of Glaucoma brings together insights, experience and ambitions from both patients and healthcare professionals to formulate a combined vision for future glaucoma care.
Through a series of articles edited by some of the UK’s leading glaucoma experts – we explore future trends and key enablers for better care including:
- The role of artificial intelligence in glaucoma management
- Innovative treatments, from medications to management
- Sustainable service delivery, improving diagnosis and stratification
- Health equity and access, ensuring those most at risk are able to access help
- Patient engagement and education, supporting patients to make informed decisions about their condition
The article series concludes with an overview of the critical catalysts for change identified by our panel of editors.
Read The Articles Here
Article 1: Introduction
A clear look at a better future for glaucoma care. Glaucoma is one of the most common causes of vision loss and blindness. More than 3% of people over 40 have glaucoma, and perhaps 10% of over-75s.
Article 2: Setting the Scene
A shared vision of the future of glaucoma care. Glaucoma patients and healthcare professionals have different perspectives on glaucoma care, but they share many of the same priorities.
Article 3: Artificial Intellegence
AI could help the highest-risk patients get glaucoma care . While artificial intelligence has many possible uses in glaucoma, its greatest potential is in identifying those at greatest risk.
Article 4: Sustainable Service Delivery
Ensuring the right patient is seen by the right person at the right time. How can the healthcare system ensure that every glaucoma patient is seen, while also maintaining empathic health professional - patient relationships.
Article 5: Innovative Treatments
The new cornucopia of treatments for glaucoma. From new types of pharmaceuticals to novel surgical approaches, there are now many more treatments available for glaucoma.
Article 6: Health Equality
Ensuring access to glaucoma care is truly equitable. Poor people and members of ethnic minorities often receive worse glaucoma care. Fixing these inequities requires a tailored approach.
Article 7: Patient Education and Engagement
People with glaucoma need clarity about their condition. Patients with glaucoma who are educated about their diagnosis are more likely to actively engage in their care and often have better outcomes.
Article 8: Conclusions and Recommendations
What if we got it right? The Future of Glaucoma Care in the UK. Shaping the future of glaucoma care at every level will not only improve patients’ lives but deliver lasting benefits for society.
About The Authors
Lina Osman
Consultant Ophthalmic surgeon with special interests in Glaucoma University
Hospitals of Leicester NHS Trust
Mohammed Abu-Bakra
Consultant Ophthalmologist King’s College
Hospital NHS Foundation Trust
Catherine Park
Specialist Optometrist
University of Manchester University NHS Foundation Trust
Michael Smith
Consultant Ophthalmologist
Royal Devon University NHS Trust
Joanne Creighton
Chief Executive
Glaucoma UK
Wai Siene Ng
Consultant Ophthalmic Surgeon
University Hospital of Wales
Anthony Khawaja
Consultant Ophthalmic Surgeon
Moorfields Eye Hospital
Imran Masood
Consultant Ophthalmic Surgeon
Birmingham and Midland Eye Centre
Andrew Tatham
Consultant Ophthalmologist
Princess Alexandra Eye Pavilion. President UK and Eire Glaucoma Society (UKEGS)
Sancy Low
Consultant Ophthalmologist and a Glaucoma Surgeon
St. Thomas’ Hospital in London and The Wimpole Eye Clinic
Nishani Amerasinghe
Consultant Ophthalmic Surgeon
University Hospital Southampton NHS Foundation Trust. Past President UK and Eire Glaucoma Society (UKEGS)
Gus Gazzard
Director of Surgery and Professor of Ophthalmology (Glaucoma Studies)
Moorfields Eye Hospital, Institute of Ophthalmology UCL and NIHR Biomedical Research Centre
About Santen
Santen is a dedicated ophthalmological pharmaceutical company with more than 130 years of experience developing innovative products that improve the lives of people living with eye conditions. From our roots in Japan to our growing presence across Europe, the US, China, and beyond, we are dedicated to the treatment of ophthalmology and we’ve continuously expanded access to innovative treatments – from dry eye and glaucoma to rare childhood conditions. Every step we take is driven by a belief that better eye health means better lives.
We are committed to accelerating change in healthcare delivery and supporting the ophthalmology community.
For more information about Santen and our vision, visit
https://www.santen.uk/.
We’re interested in your views.
Are you a healthcare professional working in glaucoma care, or a patient living with or caring for someone with glaucoma? Do you agree with the recommendations in the articles? Can more be done?
If you have any feedback or questions about the articles or their launch, please complete the contact form below.
We’ll reply as soon as we can.
© Santen 2025. medicalaffairsuk@santen.com